Changes in Beneficial Ownership · 4
Entera Bio Ltd.
ENTXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
zk2635884.xml
Filing details
- Report period
- 2026-08-07
- Issuer
- Entera Bio Ltd.
- Issuer CIK
- 0001638097
- Trading symbol
- ENTX
Reporting owner 1
- Name
- Malca Yonatan
- Reporting owner CIK
- 0001904759
- Relationship
- Director
- Address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, ISRAEL, L3, 9112002
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share | 2026-08-07 | A · Form 4[F1] | 22,815 | A | 0 | 100,231 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") awarded these shares to the Reporting Person in lieu of the cash fees the Reporting Person was entitled to for services rendered as a director of the Company for the first quarter and second quarter of 2026. This grant of shares was approved by the Board on August 5, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the shares, which occurred on August 7, 2026.↩ 1
Signature 1
- Signed
- /s/ Dana Yaacov-Garbeli, Attorney-in-Fact
- Date
- 2026-08-07